Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan.

MLA

Taga, Takashi, et al. “Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan.” Pediatric Blood & Cancer, vol. 63, no. 2, Feb. 2016, pp. 248–54. EBSCOhost, https://doi.org/10.1002/pbc.25789.

APA

Taga, T., Watanabe, T., Tomizawa, D., Kudo, K., Terui, K., Moritake, H., Kinoshita, A., Iwamoto, S., Nakayama, H., Takahashi, H., Shimada, A., Taki, T., Toki, T., Ito, E., Goto, H., Koh, K., Saito, A. M., Horibe, K., Nakahata, T., … Adachi, S. (2016). Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan. Pediatric Blood & Cancer, 63(2), 248–254. https://doi.org/10.1002/pbc.25789

Chicago

Taga, Takashi, Tomoyuki Watanabe, Daisuke Tomizawa, Kazuko Kudo, Kiminori Terui, Hiroshi Moritake, Akitoshi Kinoshita, et al. 2016. “Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan.” Pediatric Blood & Cancer 63 (2): 248–54. doi:10.1002/pbc.25789.